Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Curr Drug Saf ; 17(1): 78-80, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-34323194

RESUMEN

BACKGROUND: Pantoprazole is a Proton Pump Inhibitor, commonly used by clinicians all over the world as a gastric acid synthesis inhibitor for a wide variety of gastrointestinal disorders. The efficacy and the safety of the drug are unsurmountable. PPIs are being prescribed nowadays for unapproved indications. It is one of the widely used medications in the world. Consequently, adverse events are commonly reported nowadays with proton pump inhibitors, and it is essential to improve physician awareness regarding judicious prescribing practice. OBJECTIVE: To report a case of anaphylaxis to pantoprazole, that occurred in a patient admitted with gastrointestinal complaints. CASE SUMMARY: Within few minutes of intravenous infusion of pantoprazole, a 75-year-old female developed anaphylaxis. The adverse drug reaction was promptly diagnosed, and the patient was resuscitated. CONCLUSION: It is imperative that clinicians should be aware of this adverse effect that might occur with pantoprazole and hence be more cautious while prescribing the drug, especially in the elderly.


Asunto(s)
Anafilaxia , Inhibidores de la Bomba de Protones , 2-Piridinilmetilsulfinilbencimidazoles/efectos adversos , Anciano , Anafilaxia/inducido químicamente , Anafilaxia/diagnóstico , Femenino , Humanos , Omeprazol/efectos adversos , Pantoprazol/efectos adversos , Inhibidores de la Bomba de Protones/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...